3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
7
Urinary Bladder Neoplasms
5
Glioma
5
Lung Neoplasms
4
Esophageal Neoplasms
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma, Synovial
1
Interventions
venetoclax
5
Rituximab
4
Cyclophosphamide
4
Whole-Body Irradiation
3
Cyclosporine
3
zanubrutinib
2
pirtobrutinib
2
fludarabine phosphate
2
fludarabine
2
Prednisone
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
treosulfan
1
pomalidomide
1
obinutuzumab
1
ibrutinib
1
Vincristine
1
Tacrolimus
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
R-CHOP protocol
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Melphalan
1
Maintenance
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Radiation
×
30 days
×
Clear all
No trials found.